Verification of hub genes in the expression profile of aortic dissection

Weitie Wang1, Qing Liu2, Yong Wang1

  • 1Department of Cardiovascular Surgery, Second Hospital of Jilin University, Changchun, Jilin, China.

Plos One
|November 22, 2019
PubMed
Abstract

Insights

This study identified key genes involved in thoracic aortic dissection (TAD) pathogenesis. Cyclin-dependent kinase 1 (CDK1) showed high expression and may serve as a diagnostic biomarker and therapeutic target for TAD.

Area of Science:

  • Molecular Biology
  • Genomics
  • Biochemistry

Background:

  • Thoracic aortic dissection (TAD) is a life-threatening condition.
  • Understanding the molecular mechanisms underlying TAD is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the mRNA expression profile in human thoracic aortic dissection (TAD).
  • To identify hub messenger RNAs (mRNAs) and elucidate potential molecular mechanisms in TAD pathogenesis.
  • To explore CDK1 as a potential diagnostic biomarker and therapeutic target for TAD.

Main Methods:

  • mRNA microarray analysis of TAD and non-TAD tissues.
  • Validation using quantitative real-time PCR (qRT-PCR).
  • Bioinformatic analyses including Gene Ontology, Kyoto Encyclopedia of Genes and Genomes pathways, and protein-protein interaction (PPI) network construction.

Main Results:

  • Ten hub genes, including CDK1, were identified, with significantly increased expression in TAD samples.
  • TAD pathogenesis is associated with cell cycle, oocyte meiosis, and p53 signaling pathways.
  • High expression of CDK1 and Ki-67 in TAD tissues indicates a high proliferation state.

Conclusions:

  • CDK1 is a significantly upregulated hub gene in TAD.
  • CDK1 demonstrates potential as a diagnostic biomarker for TAD.
  • CDK1 represents a promising therapeutic target for managing TAD.

Related Concept Videos